Non-Human Primate Model of Gluten-Sensitive Enteropathy
麸质敏感性肠病的非人类灵长类动物模型
基本信息
- 批准号:8050177
- 负责人:
- 金额:$ 30.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAllelesAmericanAnimal ModelAnimalsAntibodiesAutoimmune DiseasesBarleyBiopsyBody Weight decreasedCeliac DiseaseCerealsChronicClinicalClinical ResearchCysteineDNADiarrheaDietDigestionDiseaseDisease remissionDoseEnzymesEpitheliumGastrointestinal tract structureGenesGeneticGliadinGlutenHaplotypesHealthHumanImmune responseImmunityImmunogeneticsIndividualInflammationInflammatoryIngestionIntestinal MucosaIntestinesLymphocyteMacacaMacaca mulattaMeasuresModelingMusNational Institute of Diabetes and Digestive and Kidney DiseasesOralPathogenesisPathologicPatientsPeptidesPilot ProjectsProteinsRecording of previous eventsRecoveryReportingSamplingSmall IntestinesSphingomonasSymptomsT-LymphocyteT-Lymphocyte EpitopesTherapeuticTissuesTransgenic MiceVillous AtrophyVillusWithdrawalabsorptionbasecytokinefeedingfollow-upintestinal epitheliumintraepithelialmucosa-associated lymphoid tissuenonhuman primateprolyl oligopeptidaseresearch studyskin lesionsynthetic peptidetransglutaminase 2
项目摘要
DESCRIPTION (provided by applicant): In humans, gluten-sensitive enteropathy (GSE) is typically found in individuals genetically predisposed to celiac disease (CD), and in rhesus monkeys as well as in humans it can be induced by a gluten-containing diet. We recently performed experiments where gluten-sensitive and control macaques were fed gluten- containing diets followed by gluten-free diets. Complete recovery was achieved in GSE macaques - based on withdrawal of gluten from their diet. Furthermore, we identified 2 DRB haplotypes and/or 4 DQ allelic pairs as candidate MHC II genes for immunogenetic association with gluten sensitivity in rhesus macaques. Although several useful models have been established to study CD, including transgenic mice expressing HLA-DQ2 allele, there is no satisfactory animal model that would fulfill both genetic and pathologic criteria of this autoimmune disease. We have partially characterized a rhesus GSE model. We believe that such a model will be extremely useful for studies of the immunopathogenesis and treatment of CD. To develop this model further, we plan to: Aim 1: Evaluate an association between clinical, histopathological and immunological surrogates of GSE in rhesus macaques. An association between clinical symptoms (diarrhea, weight loss, skin lesions, etc.), presence of AGA, anti-transglutaminase 2 (TG2) antibodies, villous atrophy, increased presence of IELs and inflammatory-cytokine producing intestinal T lymphocytes in macaques with clinical or subclinical GSE vs. controls will be evaluated. Aim 2: Confirm MHC II alleles that were identified in rhesus macaques as candidates for immunogenetic association with gluten sensitivity. DNA extracted from at least 100 gluten-sensitive and 100 control macaques of Indian origin will be examined for the association with 2 DRB haplotypes and/or 4 DQ allelic pairs that we recently identified as MHC II candidate alleles. We predict that analogous to celiac patients DQ2/8 association will also be confirmed in rhesus macaques with GSE. Aim 3: Evaluate the differences in a2-gliadin digestion between gluten sensitive and control macaques. In pilot study with gluten sensitive and control macaques, it was found that GSE animals but not controls, nor remitted animals, absorb undigested 33-mer across intestinal epithelium. Thus, it was proposed that systemic humoral immune response to dietary gluten is caused by absorption of undigested a2-gliadin across "leaky" epithelium in GSE macaques with proper MHC II type. Aim 4: Evaluate the oral enzyme treatments in rhesus macaques with GSE. MHC II-pre- selected macaques with gluten sensitivity will be first placed on a gluten-free diet to accomplish remission. In a follow-up gluten challenge, gluten sensitive macaques will be dosed with increasing levels of gluten and a fixed daily oral dose of prolyl endopeptidase from Sphingomonas capsulata, cysteine endoprotease EP-B2 from barley, and the two-enzymes together to evaluate their therapeutic potential.
描述(由申请方提供):在人类中,麸质敏感性肠病(GSE)通常见于遗传上易患乳糜泻(CD)的个体,在恒河猴和人类中,含麸质饮食可诱导GSE。我们最近进行了实验,其中谷蛋白敏感的猕猴和对照猕猴被喂食含谷蛋白的饮食,然后是无谷蛋白的饮食。在GSE猕猴中实现了完全恢复-基于从其饮食中去除麸质。此外,我们确定了2个DRB单倍型和/或4个DQ等位基因对作为与恒河猴麸质敏感性免疫遗传相关的候选MHC II基因。虽然已经建立了几种有用的模型来研究CD,包括表达HLA-DQ 2等位基因的转基因小鼠,但还没有令人满意的动物模型能够满足这种自身免疫性疾病的遗传和病理标准。我们已经部分地描述了恒河猴GSE模型。我们相信,这样的模型将是非常有用的CD的免疫发病机制和治疗的研究。为了进一步开发这个模型,我们计划:目的1:评价恒河猴GSE的临床,组织病理学和免疫学替代品之间的关联。临床症状(腹泻、体重减轻、皮肤病变等)之间的关联,将评价临床或亚临床GSE猕猴与对照相比是否存在阿加、抗转氨酶2(TG 2)抗体、绒毛萎缩、IEL和产生炎性细胞因子的肠T淋巴细胞的存在增加。目的2:确认在恒河猴中鉴定的MHC II等位基因作为与谷蛋白敏感性免疫遗传学关联的候选者。从至少100个面筋敏感的和100个控制猕猴的印度起源的DNA提取将被检查与2 DRB单倍型和/或4 DQ等位基因对,我们最近确定为MHC II候选等位基因的关联。我们预测,类似于乳糜泻患者DQ 2/8的关联也将在患有GSE的恒河猴中得到证实。目的3:评估谷蛋白敏感猕猴和对照猕猴之间α 2-麦醇溶蛋白消化的差异。在谷蛋白敏感猕猴和对照猕猴的初步研究中,发现GSE动物而不是对照动物,也不是缓解动物,吸收未消化的33-mer穿过肠上皮。因此,提出对膳食麸质的全身体液免疫应答是由具有适当MHC II型的GSE猕猴中未消化的α 2-麦醇溶蛋白穿过“渗漏”上皮的吸收引起的。目的4:评价口服酶治疗恒河猴GSE。MHC II预选猕猴与面筋敏感性将首先放在一个面筋免费的饮食,以实现缓解。在后续的谷蛋白激发中,谷蛋白敏感性猕猴将被给予增加水平的谷蛋白和固定的每日口服剂量的来自荚膜鞘氨醇单胞菌的脯氨酰内肽酶、来自大麦的半胱氨酸内切蛋白酶EP-B2以及这两种酶,以评估它们的治疗潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAROL SESTAK其他文献
KAROL SESTAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAROL SESTAK', 18)}}的其他基金
DEVELOPMENT OF Q PCR ASSAY FOR DETECTION OF ENTERIC CALICIVIRUSES
用于检测肠道杯状病毒的 Q PCR 检测方法的开发
- 批准号:
8358112 - 财政年份:2011
- 资助金额:
$ 30.41万 - 项目类别:
GENETIC DIVERSITY AMONG RHESUS ENTERIC CALICIVIRUSES
恒河猴肠杯状病毒的遗传多样性
- 批准号:
8358072 - 财政年份:2011
- 资助金额:
$ 30.41万 - 项目类别:
XENOBIOTIC METABOLISM AND CANCER IN GLUTEN-SENSITIVE MACAQUES
麸质敏感猕猴的异生代谢与癌症
- 批准号:
8358154 - 财政年份:2011
- 资助金额:
$ 30.41万 - 项目类别:
ROLE OF RHESUS ROTAVIRUS GENE 4 IN BILIARY ATRESIA
恒河猴轮状病毒基因 4 在胆道闭锁中的作用
- 批准号:
8358153 - 财政年份:2011
- 资助金额:
$ 30.41万 - 项目类别:
CHARACTERIZATION OF GLUTEN-SENSISTIVE RHESUS MACAQUES
麸质敏感恒河猴的特征
- 批准号:
8358073 - 财政年份:2011
- 资助金额:
$ 30.41万 - 项目类别:
NORO-, SAPO- & RHESUS ENTERIC CALICIVIRUS-SPECIFIC ANTIBODIES IN MACAQUES
NORO-、SAPO-
- 批准号:
8358093 - 财政年份:2011
- 资助金额:
$ 30.41万 - 项目类别:
DEVELOPMENT OF RT PCR ASSAY FOR QUANTITATIVE DETECTION OF ENTERIC CALICIVIRUSES
肠道杯状病毒定量检测 RT PCR 检测方法的开发
- 批准号:
8173022 - 财政年份:2010
- 资助金额:
$ 30.41万 - 项目类别:
GENETIC DIVERSITY AMONG RHESUS ENTERIC CALICIVIRUSES
恒河猴肠杯状病毒的遗传多样性
- 批准号:
8172967 - 财政年份:2010
- 资助金额:
$ 30.41万 - 项目类别:
NONINFLAMMATORY GLUTEN PEPTIDE ANALOGUES AS BIOMARKERS FOR CELIAC SPRUE
非炎症性麸质肽类似物作为乳糜泻的生物标志物
- 批准号:
8172996 - 财政年份:2010
- 资助金额:
$ 30.41万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 30.41万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 30.41万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 30.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 30.41万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 30.41万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 30.41万 - 项目类别: